Antineoplastic treatment with crizotinib during pregnancy: a case report

Authors

  • Kristian H. Jensen Department of Oncology, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark
  • Gitte Persson Department of Oncology, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark
  • Lone Storgaard Department of Obstetrics, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark
  • Birgitte B. Nielsen Department of Obstetrics, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark
  • Berit W. Pedersen Department of Obstetrics, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark
  • Lisa L. Maroun Department of Pathology, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark
  • Alwin Huitema Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands;  Department of Clinical Pharmacy, University Medical Center Utrecht Utrecht University, Utrecht, The Netherlands
  • Mette Pøhl Department of Oncology, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark

DOI:

https://doi.org/10.1080/0284186X.2018.1497302

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2019-01-02

How to Cite

Jensen, K. H., Persson, G., Storgaard, L., Nielsen, B. B., Pedersen, B. W., Maroun, L. L., … Pøhl, M. (2019). Antineoplastic treatment with crizotinib during pregnancy: a case report. Acta Oncologica, 58(1), 121–122. https://doi.org/10.1080/0284186X.2018.1497302

Issue

Vol. 58 No. 1 (2019): Acta Oncologica

Section

Articles